NEW YORK (GenomeWeb News) – Swiss proteomics firm Biognosys said this week that it has secured $1.0 million in funding in the form of a convertible loan.

The company, which specializes in targeted proteomics and mass spec-based biomarker discovery, said it will use the money to expand its commercial operations and product development.

Biognosys was spun out of Ruedi Aebersold's laboratory in 2008 at the Swiss Federal Institute of Technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.